Published in Nurs Manag (Harrow) on October 01, 1994
Regulating the pharmaceutical industry. BMJ (1997) 6.61
Rationing health care. BMJ (1996) 5.27
Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. Am J Physiol Lung Cell Mol Physiol (2008) 3.80
Promoting cost effective prescribing. BMJ (1995) 3.46
Can general practitioners counsel? J R Coll Gen Pract (1989) 2.88
The doctor, the patient, and their contract. III. Alternative contracts: are they viable? Br Med J (Clin Res Ed) (1986) 2.86
The doctor, the patient, and their contract. I. The general practitioner's contract: why change it? Br Med J (Clin Res Ed) (1986) 2.70
Something rotten in the state of clinical and economic evaluations? Health Econ (1994) 2.50
Rewarding healthcare teams. BMJ (1998) 2.47
The doctor, the patient, and their contract. II. A good practice allowance: is it feasible? Br Med J (Clin Res Ed) (1986) 2.36
Applying resource allocation formulae to constituent parts of the U.K. Lancet (1980) 2.34
On the way to Calvary. Ministers should realise the command and control model the white paper entails. BMJ (1998) 2.30
Wrong SIGN, NICE mess: is national guidance distorting allocation of resources? BMJ (2001) 2.19
Data Note--9. Measuring the social costs of addictive substances. Br J Addict (1987) 2.09
Failure of long surviving, passively enhanced kidney allografts to provoke T-dependent alloimmunity. I. Retransplantation of (AS X AUG)F1 kidneys into secondary AS recipients. J Exp Med (1979) 1.88
Efficiency in the National Health Service: lessons from abroad. Health Policy (1988) 1.79
Economic aspects of tobacco use and taxation policy. BMJ (1988) 1.70
Doctors have no time for alcohol screening. Br Med J (Clin Res Ed) (1987) 1.63
Private finance for the public good? BMJ (1996) 1.56
Regional distribution of family practitioner services: implications for National Health Service equity and efficiency. J R Coll Gen Pract (1987) 1.41
The costs of alcohol misuse. Br J Addict (1985) 1.32
Lessons from international experience in controlling pharmaceutical expenditure. III: Regulating industry. BMJ (1996) 1.30
The mental health services: a review of the statistical sources and a critical assessment of their usefulness. Br J Psychiatry (1974) 1.29
Medical manpower in the year 2000. Br Med J (1979) 1.23
Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins. J Med Chem (1998) 1.14
Estimation of life years lost from alcohol-related premature death. Alcohol Alcohol (1985) 1.13
Morbidity variation and RAWP. J Epidemiol Community Health (1990) 1.11
New Zealand's new health sector reforms: back to the future? BMJ (2001) 1.10
An outsider's view of the NHS reforms. BMJ (1994) 1.10
Teaching health economics. Br Med J (Clin Res Ed) (1986) 1.09
Skill mix changes: substitution or service development? Health Policy (1998) 1.04
Financing the U.K. national health services. Health Policy (1986) 1.02
Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers. J Med Chem (1999) 0.99
Case for auditing audit. Health Serv J (1991) 0.97
Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 Co-receptor and ligand binding function. J Biol Chem (1999) 0.96
Ethics and health care 'underfunding'. J Med Ethics (2001) 0.92
Determining value for money in day hospital care for the elderly. Age Ageing (1986) 0.90
Health care reform. Health Econ (1998) 0.89
Pharmacoepidemiology of non-steroidal anti-inflammatory drug use in Nottingham general practices. Aliment Pharmacol Ther (2000) 0.89
A nice challenge for health economics. Health Econ (2000) 0.88
Who will die and who will survive? Health Serv J (1988) 0.88
Private practice: answer or irrelevance? Br Med J (Clin Res Ed) (1984) 0.86
Translating evidence into practice. The case of influenza vaccination. Eur J Public Health (2001) 0.84
Economic aspects of addiction policy. Health Promot (1986) 0.84
Doctors and alcohol screening--the gap between attitudes and action. Health Educ J (1988) 0.83
Public opinion and rationing in the United Kingdom. Health Policy (1999) 0.83
Public and private sector interactions: an economic perspective. Soc Sci Med (1986) 0.83
A comparison of the costs and benefits of recombinant human erythropoietin (epoetin) in the treatment of chronic renal failure in 5 European countries. Pharmacoeconomics (1992) 0.82
What is to be done about fundholding? BMJ (1997) 0.81
Ethics and journal publishing: taking the debate forward. Ethics and the incentive structure. Addiction (1995) 0.80
The relevance of health economics to health promotion. WHO Reg Publ Eur Ser (1991) 0.79
Evidence based medicine. Cost effectiveness and equity are ignored. BMJ (1996) 0.79
Are drug policies based on 'fake' statistics? Addiction (1993) 0.79
Is there scope for improving the cost-effective prescribing of nonsteroidal anti-inflammatory drugs? Pharmacoeconomics (1996) 0.78
Ibuprofen versus other non-steroidal anti-inflammatory drugs: use in general practice and patient perception. Aliment Pharmacol Ther (2000) 0.77
The economics of addiction: the role of the economist in addictions research. Br J Addict (1989) 0.77
The market reform of the New Zealand health care system searching for the Holy Grail in the Antipodes. Health Policy (1994) 0.77
Thoracic size-selective sampling of fibres: performance of four types of thoracic sampler in laboratory tests. Ann Occup Hyg (2005) 0.77
Regulation of anti-hapten antibody responses in vivo: memory, carrier-specific Lyt-2+ T cells can terminate antibody production without altering the peak of response. J Immunol (1984) 0.76
Evaluating health interventions in the 21st century: old and new challenges. Health Policy (2003) 0.76
Fundholding and prescribing. Prescribing practice may have been inefficient. BMJ (1995) 0.75
Hospital and community health service costs: England and Scotland compared. Br Med J (Clin Res Ed) (1988) 0.75
Nursing shortages. Pay increases are most efficient response to labour shortages. BMJ (1996) 0.75
Secrecy in the NHS. Clinicians should not restrict access to basic information. BMJ (1995) 0.75
Health care reform in the United States. Health Econ (1992) 0.75
Drug information and cost effectiveness. Br Med J (1979) 0.75
Limits to demand for health care. Rationing is needed in a national health service. BMJ (2001) 0.75
Inequalities in health: an introduction. Health Econ (1999) 0.75
Politicians may not have same goals as clinicians with regard to mergers. BMJ (1999) 0.75
The cost of our neglect. Health Serv J (1987) 0.75
The costs of managing severe cancer pain and potential savings from transdermal administration. Eur J Cancer (1994) 0.75
Is the NHS pouring money down the drain? Health Serv Manpow Rev (1987) 0.75
British medical manpower. N Engl J Med (1979) 0.75
Addiction control policies or there's no such thing as a free lunch. Br J Addict (1985) 0.75
Performance indicators and performance assessment in the UK National Health Service: implications for management and planning. Int J Health Plann Manage (1986) 0.75
Primary care. Reassessing NHS evaluation could prove a "blooming" success. Health Soc Serv J (1984) 0.75
Budget allocation in the National Health Service. J Soc Policy (1980) 0.75
Counting the cost of alcohol: gaps in epidemiological knowledge. Community Med (1985) 0.75
Date note--5. The consumption of illicit drugs in the U.K. Br J Addict (1986) 0.75
The politics of health care. Interview by Roger Neighbour. Practitioner (1987) 0.75
Harmonisation policies in the European community and alcohol abuse. Br J Addict (1982) 0.75
The economics of alcohol abuse. Br J Addict (1981) 0.75
Geriatric day hospitals on trial. Health Soc Serv J (1985) 0.75
Data note--2. Measuring U.K. alcohol and tobacco consumption. Br J Addict (1986) 0.75
Pricing, demanders, and the supply of health care. Int J Health Serv (1979) 0.75
Graduate training in health economics at the University of York. Program Notes Assoc Univ Programs Health Adm (1982) 0.75
Community care. Health Serv J (1986) 0.75
A very British way of dying. Health Serv J (1989) 0.75
Addiction Research Centre: Hull-York, U.K. Br J Addict (1987) 0.75
Lessons from America. Health Serv J (1988) 0.75
Avarice, inefficiency, and inequality: an international health care tale. Int J Health Serv (1977) 0.75
Budgeting in health care systems. Eff Health Care (1984) 0.75
Who cares about the NHS? Health Serv J (1987) 0.75
Pricing, insurance and the National Health Service. J Soc Policy (1979) 0.75
What nursing shortage? Health Serv J (1987) 0.75
A half baked review? Health Serv J (1989) 0.75
Incentives for cost-effective physician behavior. Health Policy (1987) 0.75
Comparison of heart rate biofeedback, false biofeedback, and systematic desensitization in reducing speech anxiety: short- and long-term effectiveness. J Consult Clin Psychol (1979) 0.75
Maintaining the status quo for consultants' contracts--the case for the attack. Health Serv Manpow Rev (1987) 0.75